VH-4527079
- Generic Name
- VH-4527079
A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 86
- Registration Number
- NCT06652958
- Locations
- 🇺🇸
GSK Investigational Site, Austin, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath